Greenstreet is the CEO of Alnylam Pharmaceuticals. Over the past two decades, scientists have developed a revolutionary new class of medicines with the power to halt or even reverse disease. These ...
This press release announces settled charges brought by the SEC against GTT Communications, Inc., a multinational telecommunications and internet service provider, for failure to disclose material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results